Structure of the malaria antigen AMA1 in complex with a growth-inhibitory antibody.
Identifying functionally critical regions of the malaria antigen AMA1 (apical membrane antigen 1) is necessary to understand the significance of the polymorphisms within this antigen for vaccine development. The crystal structure of AMA1 in complex with the Fab fragment of inhibitory monoclonal anti...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2007-09-01
|
Series: | PLoS Pathogens |
Online Access: | http://europepmc.org/articles/PMC2323298?pdf=render |
id |
doaj-72a8c7e57f1147d08a0cea15dfee8740 |
---|---|
record_format |
Article |
spelling |
doaj-72a8c7e57f1147d08a0cea15dfee87402020-11-24T22:09:33ZengPublic Library of Science (PLoS)PLoS Pathogens1553-73661553-73742007-09-01391308131910.1371/journal.ppat.0030138Structure of the malaria antigen AMA1 in complex with a growth-inhibitory antibody.Andrew M ColeyAditi GuptaVince J MurphyTao BaiHanna KimMichael FoleyRobin F AndersAdrian H BatchelorIdentifying functionally critical regions of the malaria antigen AMA1 (apical membrane antigen 1) is necessary to understand the significance of the polymorphisms within this antigen for vaccine development. The crystal structure of AMA1 in complex with the Fab fragment of inhibitory monoclonal antibody 1F9 reveals that 1F9 binds to the AMA1 solvent-exposed hydrophobic trough, confirming its importance. 1F9 uses the heavy and light chain complementarity-determining regions (CDRs) to wrap around the polymorphic loops adjacent to the trough, but uses a ridge of framework residues to bind to the hydrophobic trough. The resulting 1F9-AMA1-combined buried surface of 2,470 A(2) is considerably larger than previously reported Fab-antigen interfaces. Mutations of polymorphic AMA1 residues within the 1F9 epitope disrupt 1F9 binding and dramatically reduce the binding of affinity-purified human antibodies. Moreover, 1F9 binding to AMA1 is competed by naturally acquired human antibodies, confirming that the 1F9 epitope is a frequent target of immunological attack.http://europepmc.org/articles/PMC2323298?pdf=render |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Andrew M Coley Aditi Gupta Vince J Murphy Tao Bai Hanna Kim Michael Foley Robin F Anders Adrian H Batchelor |
spellingShingle |
Andrew M Coley Aditi Gupta Vince J Murphy Tao Bai Hanna Kim Michael Foley Robin F Anders Adrian H Batchelor Structure of the malaria antigen AMA1 in complex with a growth-inhibitory antibody. PLoS Pathogens |
author_facet |
Andrew M Coley Aditi Gupta Vince J Murphy Tao Bai Hanna Kim Michael Foley Robin F Anders Adrian H Batchelor |
author_sort |
Andrew M Coley |
title |
Structure of the malaria antigen AMA1 in complex with a growth-inhibitory antibody. |
title_short |
Structure of the malaria antigen AMA1 in complex with a growth-inhibitory antibody. |
title_full |
Structure of the malaria antigen AMA1 in complex with a growth-inhibitory antibody. |
title_fullStr |
Structure of the malaria antigen AMA1 in complex with a growth-inhibitory antibody. |
title_full_unstemmed |
Structure of the malaria antigen AMA1 in complex with a growth-inhibitory antibody. |
title_sort |
structure of the malaria antigen ama1 in complex with a growth-inhibitory antibody. |
publisher |
Public Library of Science (PLoS) |
series |
PLoS Pathogens |
issn |
1553-7366 1553-7374 |
publishDate |
2007-09-01 |
description |
Identifying functionally critical regions of the malaria antigen AMA1 (apical membrane antigen 1) is necessary to understand the significance of the polymorphisms within this antigen for vaccine development. The crystal structure of AMA1 in complex with the Fab fragment of inhibitory monoclonal antibody 1F9 reveals that 1F9 binds to the AMA1 solvent-exposed hydrophobic trough, confirming its importance. 1F9 uses the heavy and light chain complementarity-determining regions (CDRs) to wrap around the polymorphic loops adjacent to the trough, but uses a ridge of framework residues to bind to the hydrophobic trough. The resulting 1F9-AMA1-combined buried surface of 2,470 A(2) is considerably larger than previously reported Fab-antigen interfaces. Mutations of polymorphic AMA1 residues within the 1F9 epitope disrupt 1F9 binding and dramatically reduce the binding of affinity-purified human antibodies. Moreover, 1F9 binding to AMA1 is competed by naturally acquired human antibodies, confirming that the 1F9 epitope is a frequent target of immunological attack. |
url |
http://europepmc.org/articles/PMC2323298?pdf=render |
work_keys_str_mv |
AT andrewmcoley structureofthemalariaantigenama1incomplexwithagrowthinhibitoryantibody AT aditigupta structureofthemalariaantigenama1incomplexwithagrowthinhibitoryantibody AT vincejmurphy structureofthemalariaantigenama1incomplexwithagrowthinhibitoryantibody AT taobai structureofthemalariaantigenama1incomplexwithagrowthinhibitoryantibody AT hannakim structureofthemalariaantigenama1incomplexwithagrowthinhibitoryantibody AT michaelfoley structureofthemalariaantigenama1incomplexwithagrowthinhibitoryantibody AT robinfanders structureofthemalariaantigenama1incomplexwithagrowthinhibitoryantibody AT adrianhbatchelor structureofthemalariaantigenama1incomplexwithagrowthinhibitoryantibody |
_version_ |
1725811306499407872 |